5-HT2A Ligands with Local Quality Substituents
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for small molecule 5-HT2 receptor ligands with improved therapeutic, absorption, distribution, pharmacokinetic, and safety profiles to effectively treat a wide array of 5-HT2 responsive conditions such as psychiatric, pain, immunological, and neurological disorders.
Innovation Solution
Development of new ligands, specifically compounds of formulas (I) and (II), which engage certain amino acid residues in the orthosteric binding pocket of the 5-HT2A receptor, offering improved potencies and efficacies for anti-inflammatory effects, and can be administered via various routes for treating conditions like inflammation, pain, depression, anxiety, and Alzheimer's disease.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing 5-HT2 receptor ligands are used, then therapeutic effects can be achieved, but the therapeutic index and safety profile are insufficient
Solution Approach 1:
The patent applies local quality by introducing specific substituents at defined positions on the phenethylamine core structure. The nitrogen substituent (R^N) at position 2 and the aromatic ring substituent (R^Ar) at position 4 are carefully selected to optimize 5-HT2A receptor binding affinity while maintaining selectivity over other serotonin receptors, thereby improving the therapeutic index and reducing off-target side effects.
Solution Approach 2:
The patent employs parameter changes by systematically varying the chemical structure of the ligands through different substituent groups (R^N, R^Ar, R^X) and their positions. This includes modifying the nitrogen substituent to be hydrogen, alkyl, aryl, or heteroaryl groups, and adjusting the aromatic ring substituents to achieve optimal pharmacokinetic properties, binding affinity, and safety profile.
2Productivity
If small molecule 5-HT2 receptor ligands are developed, then improved pharmacokinetic profiles can be achieved, but the complexity of optimizing multiple properties increases
Solution Approach 1:
The patent applies segmentation by dividing the ligand molecule into distinct functional regions: the core phenethylamine structure, the nitrogen substituent (R^N), and the aromatic ring substituent (R^Ar). Each segment can be independently optimized for specific properties such as metabolic stability, blood-brain barrier penetration, and receptor binding, allowing systematic improvement of pharmacokinetic profiles without overwhelming molecular complexity.
Solution Approach 2:
The patent achieves universality by designing a core phenethylamine structure that serves multiple functions: providing the essential pharmacophore for 5-HT2A receptor binding, allowing for diverse substituent attachment to optimize pharmacokinetic properties, and maintaining structural flexibility for adapting to different therapeutic indications while following the same design framework.
Data Source
AI summary
The invention features indolealkylamine compounds and pharmaceutical compositions useful for treating 5-HT2 responsive conditions. Also provided are methods of using the compounds or compositions of the invention for treating 5-HT2 responsive conditions such as depression or inflammation in a subject in need thereof.